Cargando…
Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.
Serum samples from 82 patients with epithelial ovarian cancer, previously assayed for CA125, were assayed for circulating colony-stimulating factor 1 (CSF-1). An elevated CSF-1 concentration (> 450 U ml-1 or > 5.42 ng ml-1) was significantly associated with a worse survival (P = 0.02). The pre...
Autores principales: | Scholl, S. M., Bascou, C. H., Mosseri, V., Olivares, R., Magdelenat, H., Dorval, T., Palangié, T., Validire, P., Pouillart, P., Stanley, E. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968706/ https://www.ncbi.nlm.nih.gov/pubmed/8297732 |
Ejemplares similares
-
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
por: Pierga, J-Y, et al.
Publicado: (2000) -
Postirradiation Sarcoma: Clinicopathologic Features and Role of Chemotherapy in the Treatment Strategy
por: des Guetz, Gaetan, et al.
Publicado: (2009) -
Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.
por: Tartour, E., et al.
Publicado: (1994) -
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
por: Pierga, J-Y, et al.
Publicado: (2003) -
Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90).
por: Pierga, J. Y., et al.
Publicado: (1998)